drugset / Trial / NCT00308880

Tranexamic Acid and Head and Neck Surgery Patients

NCT00308880

Phase 3 Unknown 80 enrolled Taichung Veterans General Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Tranexamic acid belongs to fibrinolytic inhibitors. Several prospective randomized clinical trials have proved its effectiveness in reducing intra-operative and post-operative bleeding in orthopedic and cardiovascular surgeries. However, there is little study about tranexamic acid in reducing post-operative bleeding in head and neck surgery. So the aim of this study is to investigate if tranexamic acid could reduce post-operative bleeding via prospective double-blinded randomized clinic trial.

Timeline

Start
2006-03
Primary completion
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule